International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 4 , Pages 975-980 , 15 November 2006

Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy

Received 10 April 2006 ,Revised 13 June 2006 ,Accepted 20 June 2006.

References 

  1. Boyer AL, Geis P, Grant W, et al. Carol M (Modulated beam conformal therapy for head and neck tumors). Int J Radiat Oncol Biol Phys. 1997;39:227–236
  2. Braaksma MM, Wijers OB, van Sornsen de Koste JR, et al. Optimisation of conformal radiation therapy by intensity modulation (Cancer of the larynx and salivary gland function). Radiother Oncol. 2003;66:291–302
  3. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study. Int J Radiat Oncol Biol Phys. 2000;46:195–205
  4. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329–337
  5. Jen YM, Shih R, Lin YS, et al. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol. 2005;75:204–209
  6. Astreinidou E, Dehnad H, Terhaard CH, et al. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys. 2004;58:124–131
  7. Maes A, Weltens C, Flamen P, et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol. 2002;63:203–211
  8. Chao KS, Majhail N, Huang C, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol. 2001;61:275–280
  9. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands logic conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
  10. Bussels B, Maes A, Flamen P, et al. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol. 2004;73:297–306
  11. Scrimger RA, Stavrev P, Parliament MB, et al. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: Evidence of significant recovery effect. Int J Radiat Oncol Biol Phys. 2004;60:178–185
  12. Roesink JM, Moerland MA, Battermann JJ, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotheraphy in the head-and-neck region. Int J Radiat Oncol Biol Phys. 2001;51:938–946
  13. Roesink JM, Schipper M, Busschers W, et al. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: Implications for future trials. Int J Radiat Oncol Biol Phys. 2005;63:1006–1009
  14. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–916
  15. Kosuda S, Satoh M, Yamamoto F, et al. Assessment of salivary gland dysfunction logic chemoradiotherapy using quantitative salivary gland scintigraphy. Int J Radiat Oncol Biol Phys. 1999;45:379–384
  16. Prins-Braam PM, Raaijmakers CP, Terhaard CH. Location of cervical lymph node metastases in oropharyngeal and hypopharyngeal carcinoma: Implications for cranial border of elective nodal target volumes. Int J Radiat Oncol Biol Phys. 2004;58:132–138
  17. van Asselen B, Dehnad H, Raaijmakers CP, et al. The dose to the parotid glands with IMRT for oropharyngeal tumors: The effect of reduction of positioning margins. Radiother Oncol. 2002;64:197–204
  18. Braam PM, Roesink JM, Moerland MA, et al. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:659–664
  19. LENT SOMA. tables. Radiother Oncol. 1995;35:17–60
  20. Malouf JG, Aragon C, Henson BS, et al. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev. 2003;27:305–310
  21. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results. Int J Radiat Oncol Biol Phys. 1996;36:469–480
  22. Blanco AI, Chao KSC, El Naqa I, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055–1069
  23. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors logic parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695–704
  24. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report. Int J Radiat Oncol Biol Phys. 2005;63:725–731
  25. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61–70
  26. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663–673
  27. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005;74:251–258

 Supported by Grant No. UU 2001-2468 from the Dutch Cancer Society.

PII: S0360-3016(06)01112-6

doi: 10.1016/j.ijrobp.2006.06.045

International Journal of Radiation Oncology * Biology * Physics
Volume 66, Issue 4 , Pages 975-980 , 15 November 2006